Evaluation of fasting plasma insulin concentration as an estimate of insulin action in nondiabetic individuals: Comparison with the homeostasis model assessment of insulin resistance (HOMA-IR)

Acta Diabetologica

Volumn 51, Issue 2, 2014, Pages 193-197

  Abbasi, Fahim ^a   Okeke, Queendenise ^a   Reaven, Gerald M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fasting insulin; High density lipoprotein cholesterol; Homeostasis model assessment of insulin resistance; Insulin resistance; Steady state plasma glucose; Triglycerides

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FASTING PLASMA INSULIN; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; MALE; MATHEMATICAL ANALYSIS; METABOLIC PARAMETERS; NORMAL HUMAN; PRIORITY JOURNAL; STEADY STATE PLASMA GLUCOSE; BLOOD; HOMEOSTASIS; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PHYSIOLOGY;

ADULT; BLOOD GLUCOSE; CHOLESTEROL, HDL; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES;

EID: 84898479763     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0461-2     Document Type: Article

References (23)

1. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM (2000) Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 23:171-175
2. Facchini FS, Hua N, Abbasi F, Reaven GM (2001) Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 86:3574-3578
3. Yip J, Facchini FS, Reaven GM (1998) Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83:2773-2776
4. Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607
5. Einhorn D, Reaven GM, Cobin RH et al (2003) American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9:237-252
6. Reaven GM (2005) Why syndrome X? From Harold Himsworth to the insulin resistance syndrome. Cell Metab 1:9-14
7. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
8. Olefsky J, Farquhar JW, Reaven G (1973) Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes 22:507-513
9. Greenfield MS, Doberne L, Kraemer F, Tobey T, Reaven G (1981) Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 30:387-392
10. Pei D, Jones CN, Bhargava R, Chen YD, Reaven GM (1994) Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 37:843-845
11. Shen SW, Reaven GM, Farquhar JW (1970) Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 49:2151-2160
12. Laws A, Reaven GM (1992) Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Intern Med 231:25-30
13. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215-2221
14. Kahn SE, Haffner SM, Heise MA et al (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355:2427-2443
15. Reaven GM (1995) Effect of metformin on various aspects of glucose, insulin and lipid metabolism in patients with non-insulin-dependent diabetes mellitus with varying degrees of hyperglycemia. Diabetes Metab Rev 11(Suppl 1):S97-108
16. Wu MS, Johnston P, Sheu WH et al (1990) Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care 13:1-8
17. Kim SH, Reaven GM (2008) Isolated impaired fasting glucose and peripheral insulin sensitivity: not a simple relationship. Diabetes Care 31:347-352
18. Bonora E, Targher G, Alberiche M et al (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63
19. Lansang MC, Williams GH, Carroll JS (2001) Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension. Am J Hypertens 14:51-53
20. Lorenzo C, Hazuda HP, Haffner SM (2012) Insulin resistance and excess risk of diabetes in Mexican-Americans: the San Antonio Heart Study. J Clin Endocrinol Metab 97:793-799
21. Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K (2001) Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J 48:81-86
22. Lillioja S, Mott DM, Spraul M et al (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:1988-1992
23. Reaven G (2011) Wanted!: a standardized measurement of plasma insulin concentration. Arterioscler Thromb Vasc Biol 31:954-955